New Ready-to-Use IG Therapy Approved for Primary Immunodeficiency
The FDA has approved GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with ≤2 µg/mL IgA in a 10% solution for intravenous or subcutaneous use in individuals aged two years and older with primary immunodeficiency (PI).
Visit Us:-https://mdnewsline.com/new-rea....dy-to-use-ig-therapy
